MARGARET SCHULTHEISS: Open Payments
NPI 1053982405 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 23 payments from 5 companies in 2025. Trend: 2023 $61 · 2024 $231 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $211 |
| Stemline Therapeutics Inc. | 6 | $135 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: KISQALI, Orserdu, Enhertu, Phesgo, Itovebi, CALQUENCE.
Industry payments across NY — which companies pay providers there.
